# Catherine J. Pearce

> Catherine J. Pearce is the Cincinnati-based CEO and founder of AllRock Bio and a co-founder of JucaBio, CinRx Pharma and CinCor Pharma. She helped build six portfolio companies at CinRx and led CinCor’s clinical-stage function through its acquisition by AstraZeneca in February 2023. Her education combines biology, business and doctoral study, and her public leadership work includes mentorship, women’s participation in executive roles and service to Xavier University.

- **Role:** CEO and Founder at AllRock Bio
- **Organizations:** AllRock Bio, JucaBio, CinCor Pharma, CinRx Pharma, Teva Pharmaceuticals, Medpace, Merck, Roche, Xavier University
- **Education:** Bachelor’s degree in Biology, Xavier University, Master of Business Administration, Xavier University, Doctor of Health Science, Nova Southeastern University
- **Known for:** Co-founded CinRx and helped build six portfolio companies., Created and led CinCor’s clinical-stage function through its 2023 acquisition., CinCor was acquired for approximately $1.3 billion upfront, with contingent consideration bringing potential transaction value to approximately $1.8 billion.

## Career timeline

- **—** — Began her career as a sales representative at Roche; subsequently worked at Merck, Medpace and Teva.
- **2015** — Co-founded CinRx Pharma with Jon Isaacsohn.
- **2015-2019** — Helped build six CinRx portfolio companies, including CinCor.
- **2020** — Joined Xavier University’s President’s Advisory Council.
- **2022** — Appointed to Xavier University’s Board of Trustees for a term beginning July 1.
- **2023** — CinCor’s acquisition by AstraZeneca completed on February 24; subsequently co-founded JucaBio.
- **2024-04** — Founded AllRock Bio.
- **2024-05** — Received Xavier’s Distinguished Alumni Award.
- **2025-09** — AllRock announced a $50 million Series A co-led by Versant Ventures and Westlake BioPartners.

## Achievements

- Co-founded CinRx and helped build six portfolio companies.
- Created and led CinCor’s clinical-stage function through its 2023 acquisition.
- CinCor was acquired for approximately $1.3 billion upfront, with contingent consideration bringing potential transaction value to approximately $1.8 billion.
- Led AllRock as it announced a $50 million Series A in September 2025.
- Recipient of Xavier University’s 2024 Distinguished Alumni Award.

## Latest updates

- **2026-02** — Joined Tanya Bos and Emma Tinsley for a Lift Up broadcast on women’s leadership in scientific innovation.
- **2026-06** — Discussed financing, flexible workplaces and preserving established teams in an industry interview.
- **2026-06** — Publicly supported the FC Cincinnati Foundation and reflected on the value of community support for youth athletics.

## Links

- LinkedIn: https://www.linkedin.com/in/catherine-j-pearce-mba-dhsc-822a401/

---

Profile page: https://yespress.io/catherine-j-pearce
Published by YesPress — https://yespress.io
Last updated: 2026-10-15